Employee benefit plans play a major role in financing access to prescription medicines for the majority of Canadians who rely on these plans for financial security.
Fraser Group provides the pharmaceutical industry with information, research and consulting assistance to help the industry better understand and work work more effectively with plan sponsors and insurance organizations.
In a series of research projects since 1995, Fraser Group has developed considerable expertise relating to the mixed public/private system of drug insurance in Canada. Fraser Group research on this issue has been used by the insurance industry, the pharmaceutical industry, the Government of Canada and non-profit organizations.
Both Senate and House of Commons sub-committees have invited Fraser Group to make presentations on the issue of catastrophic drug expense.
Our extensive data resources, deep understanding of private benefit plans and access to insurance payers can assist in assessing market opportunities and in developing market access plans.